scemblix
novartis europharm limited - asciminib hydrochloride - leukémia, mielogén, krónikus, bcr-abl pozitív - daganatellenes szerek - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
sustac mite 2,6 mg retard tabletta
krka d.d., - gliceril trinitrate -
sustac forte 6,4 mg retard tabletta
krka d.d., - gliceril trinitrate -
paniverin tabletta
sanofi-aventis zrt. - a nikotinsav; drotaverine -
glucoplasmal 3,5% infúzió, 1000 ml
b. braun melsungen ag - aminosavak; glükóz -
pädamin infúzió, 250 ml
fresenius kabi ag - aminosavak -
vamin 14 elektrolyte-free infúzió
fresenius kabi ag - aminosavak -
vamin 14 infúzió
fresenius kabi ag - aminosavak -
vamin 18 elektrolyte-free infúzió
fresenius kabi ag - aminosavak -
clinomel n6-900 infúzió 1000 ml
baxter (hungary) kft. - aminosavak -